Literature DB >> 20141097

Cardiomyopathy: an overview.

Randell K Wexler1, Terry Elton, Adam Pleister, David Feldman.   

Abstract

Cardiomyopathy is an anatomic and pathologic diagnosis associated with muscle or electrical dysfunction of the heart. Cardiomyopathies represent a heterogeneous group of diseases that often lead to progressive heart failure with significant morbidity and mortality. Cardiomyopathies may be primary (i.e., genetic, mixed, or acquired) or secondary (e.g., infiltrative, toxic, inflammatory). Major types include dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Although cardiomyopathy is asymptomatic in the early stages, symptoms are the same as those characteristically seen in any type of heart failure and may include shortness of breath, fatigue, cough, orthopnea, paroxysmal nocturnal dyspnea, and edema. Diagnostic studies include B-type natriuretic peptide levels, baseline serum chemistries, electrocardiography, and echocardiography. Treatment is targeted at relieving the symptoms of heart failure and reducing rates of heart failure-related hospitalization and mortality. Treatment options include pharmacotherapy, implantable cardioverter-defibrillators, cardiac resynchronization therapy, and heart transplantation. Recommended lifestyle changes include restricting alcohol consumption, losing weight, exercising, quitting smoking, and eating a low-sodium diet. Copyright (c) 2009 American Academy of Family Physicians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20141097      PMCID: PMC2999879     

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  32 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

Review 3.  B-type natriuretic peptide in the diagnosis and management of congestive heart failure.

Authors:  A Maisel
Journal:  Cardiol Clin       Date:  2001-11       Impact factor: 2.213

4.  Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.

Authors:  L Cabanes; B Richaud-Thiriez; Y Fulla; F Heloire; C Vuillemard; S Weber; D Dusser
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

5.  Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy.

Authors:  S M Rivenes; D L Kearney; E O Smith; J A Towbin; S W Denfield
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

6.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

7.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

Review 8.  Management strategies for stage-D patients with acute heart failure.

Authors:  David Feldman; Doron M Menachemi; William T Abraham; Randell K Wexler
Journal:  Clin Cardiol       Date:  2008-07       Impact factor: 2.882

9.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Authors:  A Hjalmarson; S Goldstein; B Fagerberg; H Wedel; F Waagstein; J Kjekshus; J Wikstrand; D El Allaf; J Vítovec; J Aldershvile; M Halinen; R Dietz; K L Neuhaus; A Jánosi; G Thorgeirsson; P H Dunselman; L Gullestad; J Kuch; J Herlitz; P Rickenbacher; S Ball; S Gottlieb; P Deedwania
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

10.  Coronary bypass surgery with or without surgical ventricular reconstruction.

Authors:  Robert H Jones; Eric J Velazquez; Robert E Michler; George Sopko; Jae K Oh; Christopher M O'Connor; James A Hill; Lorenzo Menicanti; Zygmunt Sadowski; Patrice Desvigne-Nickens; Jean-Lucien Rouleau; Kerry L Lee
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

View more
  39 in total

1.  Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.

Authors:  Evgenios A Neofytou; Edwin Chang; Bhagat Patlola; Lydia-Marie Joubert; Jayakumar Rajadas; Sanjiv S Gambhir; Zhen Cheng; Robert C Robbins; Ramin E Beygui
Journal:  J Biomed Mater Res A       Date:  2011-05-31       Impact factor: 4.396

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  A Restrictive Cardiomyopathy Mutation in an Invariant Proline at the Myosin Head/Rod Junction Enhances Head Flexibility and Function, Yielding Muscle Defects in Drosophila.

Authors:  Madhulika Achal; Adriana S Trujillo; Girish C Melkani; Gerrie P Farman; Karen Ocorr; Meera C Viswanathan; Gaurav Kaushik; Christopher S Newhard; Bernadette M Glasheen; Anju Melkani; Jennifer A Suggs; Jeffrey R Moore; Douglas M Swank; Rolf Bodmer; Anthony Cammarato; Sanford I Bernstein
Journal:  J Mol Biol       Date:  2016-04-20       Impact factor: 5.469

4.  Gravitational Influence on Intraocular Pressure: Implications for Spaceflight and Disease.

Authors:  Alex S Huang; Michael B Stenger; Brandon R Macias
Journal:  J Glaucoma       Date:  2019-08       Impact factor: 2.503

Review 5.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 6.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

7.  Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.

Authors:  Hanna J Tadros; Chelsea S Life; Gustavo Garcia; Elisa Pirozzi; Edward G Jones; Susmita Datta; Michelle S Parvatiyar; P Bryant Chase; Hugh D Allen; Jeffrey J Kim; Jose R Pinto; Andrew P Landstrom
Journal:  J Mol Cell Cardiol       Date:  2020-04-09       Impact factor: 5.000

Review 8.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Authors:  DeLisa Fairweather; Michelle A Petri; Michael J Coronado; Leslie T Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

9.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

10.  Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway.

Authors:  Lo Lai; Lin Yan; Shumin Gao; Che-Lin Hu; Hui Ge; Amy Davidow; Misun Park; Claudio Bravo; Kousaku Iwatsubo; Yoshihiro Ishikawa; Johan Auwerx; David A Sinclair; Stephen F Vatner; Dorothy E Vatner
Journal:  Circulation       Date:  2013-03-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.